[go: up one dir, main page]

WO1999051299A3 - Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables - Google Patents

Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables Download PDF

Info

Publication number
WO1999051299A3
WO1999051299A3 PCT/US1999/005036 US9905036W WO9951299A3 WO 1999051299 A3 WO1999051299 A3 WO 1999051299A3 US 9905036 W US9905036 W US 9905036W WO 9951299 A3 WO9951299 A3 WO 9951299A3
Authority
WO
WIPO (PCT)
Prior art keywords
radioactivable
isotope
composition
beneficiated
isotopic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/005036
Other languages
English (en)
Other versions
WO1999051299A2 (fr
Inventor
Stanley Satz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIONUCLEONICS Inc
Original Assignee
BIONUCLEONICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/038,560 external-priority patent/US6187037B1/en
Application filed by BIONUCLEONICS Inc filed Critical BIONUCLEONICS Inc
Priority to CA002323440A priority Critical patent/CA2323440A1/fr
Priority to JP2000542068A priority patent/JP2003518392A/ja
Priority to AU50784/99A priority patent/AU5078499A/en
Priority to KR1020007010154A priority patent/KR20010041861A/ko
Priority to EP99935270A priority patent/EP1284684A2/fr
Publication of WO1999051299A2 publication Critical patent/WO1999051299A2/fr
Anticipated expiration legal-status Critical
Publication of WO1999051299A3 publication Critical patent/WO1999051299A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1002—Intraluminal radiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne des compositions pouvant être radioactivées, de préférence des compositions d'alliages métalliques contenant un métal qui possède des caractéristiques de mémoire de forme, et au moins un isotope pouvant être radioactivé qui comporte un élément de la série des lanthanides ou des mélanges d'éléments de la série des lanthanides, ou un autre isotope approprié. L'isotope pouvant être radioactivé est présent selon une concentration suffisante (par rapport aux autres constituants de la composition) pour permettre l'administration d'une dose de rayonnement efficace à un tissu cible en vue d'atteindre un objectif thérapeutique spécifié. Une des applications les plus avantageuses et utiles de la composition est la formation de dispositifs médicaux utiles pour le traitement d'affections des artères coronaires et la réduction de la prolifération de cellules cancéreuses. Dans un des modes de réalisation préférés de l'invention, un isotope pouvant être radioactivé est incorporé, par une combinaison enrichie en isotopes, à une matière de matrice telle qu'un alliage de nickel/titane (p. ex. alliages de métaux du type nitinol), ou par une combinaison enrichie en isotopes à un polymère biodégradable organique naturel ou synthétique de manière à former une solution solide ; et l'alliage ou la solution solide obtenu(e) est ensuite façonné(e) en une endoprothèse ou en une autre forme appropriée pour l'administration sélective et ciblée de quantités thérapeutiques et efficaces de formes posologiques faibles de rayonnement (principalement de particules bêta) à un site ou à un tissu spécifique du corps humain.
PCT/US1999/005036 1998-03-11 1999-03-10 Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables Ceased WO1999051299A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002323440A CA2323440A1 (fr) 1998-03-11 1999-03-10 Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables
JP2000542068A JP2003518392A (ja) 1998-03-11 1999-03-10 植え込み型医療用デバイスの製造に適した放射化可能組成物
AU50784/99A AU5078499A (en) 1998-03-11 1999-03-10 Radioactivable composition suitable for fabrication of implantable medical devices
KR1020007010154A KR20010041861A (ko) 1998-03-11 1999-03-10 이식 가능한 의료 기기의 제조에 적합한 방사선 활성 조성물
EP99935270A EP1284684A2 (fr) 1998-03-11 1999-03-10 Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/038,560 1998-03-11
US09/038,560 US6187037B1 (en) 1998-03-11 1998-03-11 Metal stent containing radioactivatable isotope and method of making same
US13859498A 1998-08-22 1998-08-22
US09/138,594 1998-08-22

Publications (2)

Publication Number Publication Date
WO1999051299A2 WO1999051299A2 (fr) 1999-10-14
WO1999051299A3 true WO1999051299A3 (fr) 2002-11-14

Family

ID=26715320

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/005036 Ceased WO1999051299A2 (fr) 1998-03-11 1999-03-10 Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables

Country Status (5)

Country Link
EP (1) EP1284684A2 (fr)
JP (1) JP2003518392A (fr)
KR (1) KR20010041861A (fr)
AU (1) AU5078499A (fr)
WO (1) WO1999051299A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19953636A1 (de) * 1999-11-09 2001-05-23 Karlsruhe Forschzent Radioaktive Materialien
AU1660901A (en) * 1999-11-18 2001-05-30 Howard L. Schrayer Device for the inhibition of cellular proliferation
EP1232770A1 (fr) 2001-02-15 2002-08-21 AEA Technology QSA GmbH Capsule radioactive
EP1232769A1 (fr) * 2001-02-15 2002-08-21 AEA Technology QSA GmbH Capsule fabriquée avec du Pd-103
US6537195B2 (en) 2001-05-07 2003-03-25 Xoft, Microtube, Inc. Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
US7018371B2 (en) 2001-05-07 2006-03-28 Xoft, Inc. Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
JP4886939B2 (ja) * 2001-07-19 2012-02-29 真也 岡崎 生体内留置用ヨウ素放出性治療材料およびステント
US8945207B2 (en) 2010-12-20 2015-02-03 Graftcraft I Göteborg Ab Removable stent and method of production
AU2010366132B2 (en) 2010-12-20 2015-05-21 Graftcraft I Goteborg Ab Removable stent and method of production
KR101550370B1 (ko) * 2013-12-26 2015-09-07 한국원자력의학원 저선량 방사선을 이용한 손상된 연골세포의 복구방법
RU2686483C2 (ru) * 2015-03-12 2019-04-29 Утах-Инха Ддс Энд Эдвансд Терапьютикс Рисёч Сентер Стент с покрытием из функционального материала на ячейках стента
WO2019183724A1 (fr) 2018-03-26 2019-10-03 Triumf, A Joint Venture Of The Governors Of The University Of Alberta, The University Of British Columbia, The Governors Of The University Of Calgary, Carleton University, University Of Guelph, Mcmaster University, University Of Manitoba, Universite De Montreal, Queen's University, University Of Reg Systèmes, appareil et procédés pour séparer de l'actinium, du radium et du thorium

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795286A (en) * 1996-08-15 1998-08-18 Cathco, Inc. Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation
US5843163A (en) * 1996-06-06 1998-12-01 Wall; William H. Expandable stent having radioactive treatment means
US5865720A (en) * 1997-03-06 1999-02-02 Scimed Life Systems, Inc. Expandable and retrievable radiation delivery system
US5919126A (en) * 1997-07-07 1999-07-06 Implant Sciences Corporation Coronary stent with a radioactive, radiopaque coating

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843163A (en) * 1996-06-06 1998-12-01 Wall; William H. Expandable stent having radioactive treatment means
US5795286A (en) * 1996-08-15 1998-08-18 Cathco, Inc. Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation
US5865720A (en) * 1997-03-06 1999-02-02 Scimed Life Systems, Inc. Expandable and retrievable radiation delivery system
US5919126A (en) * 1997-07-07 1999-07-06 Implant Sciences Corporation Coronary stent with a radioactive, radiopaque coating

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US7604703B2 (en) 2000-09-18 2009-10-20 Boston Scientific Scimed, Inc. Primarily niobium stent
US7582112B2 (en) 2003-02-10 2009-09-01 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication

Also Published As

Publication number Publication date
AU5078499A (en) 1999-10-25
JP2003518392A (ja) 2003-06-10
EP1284684A2 (fr) 2003-02-26
WO1999051299A2 (fr) 1999-10-14
KR20010041861A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
DE60217704T2 (de) Verbesserte endoprothetische vorrichtung
WO1999051299A3 (fr) Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables
EP1562565B1 (fr) Utilisation d'un ou de plusieurs elements du groupe rassemblant l'yttrium, le neodyme et le zirconium
JP2735689B2 (ja) 血管植込み物
DE60034317T2 (de) Medizinische instrumente und vorrichtungen mit verbesserter ultraschall-sichtbarkeit
CN104146795B (zh) 可降解的植入式医疗装置
DE69932183T2 (de) ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS
CA2323440A1 (fr) Composition pouvant etre radioactivee convenant pour la fabrication de dispositifs medicaux implantables
JP2002502638A (ja) 軟ｘ線を放射する医療器具
US20010047185A1 (en) Radioactivatable composition and implantable medical devices formed therefrom
EP2457601B1 (fr) Composite de marqueur et implant médical doté d'un marqueur de radiographie
JP2003513938A (ja) 希土類を含有している混合物及びその使用
US6241719B1 (en) Method for forming a radioactive stent
Trepanier et al. Corrosion resistance and biocompatibility of passivated NiTi
DE102006039346A1 (de) Biokorrodierbares metallisches Implantat mit einer Beschichtung oder Kavitätenfüllung aus einem PEG/PLGA-Copolymer
EP3610894B1 (fr) Dispositifs médicaux implantables comprenant des alliages biodégradables ayant des vitesses de dégradation augmentés
JP2001509493A (ja) 放射送達構造体の調製およびシール化のための方法およびシステム
CN104593650A (zh) 一种具有抗菌功能可降解吸收的镁锌铜合金及其应用
DE102006038236A1 (de) Biodegradierbarer Stent mit einer aktiven Beschichtung
CN105536048B (zh) 一种新型可降解骨植入物及其制备方法
Assad et al. A new porous titanium–nickel alloy: part 2. Sensitization, irritation and acute systemic toxicity evaluation
CN105568103A (zh) 一种可降解生物医用镁合金
CA2385369C (fr) Source de rayonnement sous forme de cable pour radiotherapie endovasculaire
US20060106273A1 (en) Directional-ionizing energy emitting implant
DE102008040572A1 (de) Implantat mit Beschichtung

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN IL IN JP KR MX TR

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT AU, CN, IL, IN, TR, EA (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM))

ENP Entry into the national phase

Ref document number: 2323440

Country of ref document: CA

Ref country code: CA

Ref document number: 2323440

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 542068

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1020007010154

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1999935270

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020007010154

Country of ref document: KR

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN IL IN JP KR MX TR

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 1999935270

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999935270

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1020007010154

Country of ref document: KR